Ye T. Zhang
Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, 100021, China
Beijing, 100021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 79 publications
Induction chemotherapy for locally advanced OPSCC: real-world evidence and HPV-dependent prognostic value of treatment response.
Journal: Radiation oncology (London, England)
Published: December 22, 2025
Neoadjuvant ctDNA-MRD monitoring uncovers occult progression despite radiologic response in locally advanced hypopharyngeal carcinoma: a case report.
Journal: Frontiers in oncology
Published: November 20, 2025
Neoadjuvant immunochemotherapy followed by definitive radiotherapy in locally advanced head and neck squamous cell carcinoma: two-year survival outcomes.
Journal: Cancer immunology, immunotherapy : CII
Published: November 08, 2025
Childhood Nasopharyngeal Carcinoma: A Rare Disease With Distinct Features and Favorable Prognosis.
Journal: International journal of radiation oncology, biology, physics
Published: September 17, 2025
Expert consensus on the combination of Anti-EGFR monoclonal antibodies and immune checkpoint inhibitors in the treatment of head and neck squamous cell carcinoma.
Journal: Cancer treatment reviews
Published: September 08, 2025
Peripheral immune and inflammatory markers as predictors of neoadjuvant immunotherapy response in head and neck squamous cell carcinoma.
Journal: Annals of medicine
Published: June 23, 2025
Tumor potential biomarker: ferritin heavy chain promotes proliferation and migration of oral squamous cell carcinoma.
Journal: Oral surgery, oral medicine, oral pathology and oral radiology
Published: June 09, 2025
Cavernous sinus syndrome in a patient with occult nasopharyngeal carcinoma: A diagnostic challenge.
Journal: Oral oncology
Published: April 11, 2025
Trends and epidemiology of human papillomavirus-related oropharyngeal cancer in Chinese populations from 2010 to 2024.
Journal: International journal of cancer
Published: March 26, 2025
Treatment response-adapted risk index model for survival prediction and adjuvant chemotherapy selection in nonmetastatic nasopharyngeal carcinoma.
Journal: NPJ digital medicine
Published: February 27, 2025
Last Updated: 09/26/2026